Abstract

http://ssrn.com/abstract=982468
 
 

Footnotes (152)



 


 



The Food and Drug Administration's Evolving Regulation of Press Releases: Limits and Challenges


William W. Vodra


Arnold & Porter

Nathan Cortez


Southern Methodist University - Dedman School of Law

David E. Korn


Pharmaceutical Research and Manufacturers of America (PhRMA)


Food and Drug Law Journal, Vol. 61, p. 623, 2006

Abstract:     
The Food and Drug Administration (FDA) has developed an informal framework for regulating press releases by drug and medical device companies. FDA asserted jurisdiction over press releases based on its authority over labeling and advertising, and over the past 20 years, the agency has both broadened and scaled back its claims to authority over press statements.

Despite a somewhat predictable framework for anticipating how FDA regulates press materials, the agency's approach appears to be in flux. FDA will not tolerate false or misleading statements in press materials, but there are legal and practical limits to its regulation in this area. The agency has had to adjust its approach to account for First Amendment concerns and resource limitations, which has led FDA to cooperate with the Securities and Exchange Commission (SEC), and take more creative responses to allegedly violative press materials.

This article discusses how FDA has regulated press materials in the past, and how recent developments may signal new directions in the agency's regulatory approach. The article proposes a framework for evaluating whether FDA might assert jurisdiction, and what the rules are if it does. The article considers the legal theories behind FDA's approach and the implications for manufacturers.

Number of Pages in PDF File: 31

Keywords: FDA, press release, media statement, First Amendment, commercial speech, pharmaceutical, device, regulation, health, administrative, agency

Accepted Paper Series





Download This Paper

Date posted: April 25, 2007  

Suggested Citation

Vodra, William W. and Cortez, Nathan and Korn, David E., The Food and Drug Administration's Evolving Regulation of Press Releases: Limits and Challenges. Food and Drug Law Journal, Vol. 61, p. 623, 2006. Available at SSRN: http://ssrn.com/abstract=982468

Contact Information

William W. Vodra
Arnold & Porter ( email )
555 12th Street, NW
STE 900
Washington, DC 20004
United States
Nathan Cortez (Contact Author)
Southern Methodist University - Dedman School of Law ( email )
P.O. Box 750116
Dallas, TX 75275
United States
(214) 768-1002 (Phone)

David E. Korn
Pharmaceutical Research and Manufacturers of America (PhRMA) ( email )
1100 Fifteenth Street, NW
Washington, DC 20005
United States
Feedback to SSRN


Paper statistics
Abstract Views: 1,667
Downloads: 224
Download Rank: 81,423
Footnotes:  152

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo8 in 0.297 seconds